3SOF

I've been watching HCTL since the big 250% run up on 11/29 where it opened @ 1.24 and shot up to 4.30, it has dropped back to the 1.70's . It looks like the bottom might be in.I bought some in the 1.70's yesterday and buying more today.This is a low float 2.8 mil. share stock so it can move fast.Here is the news that made it run on 11/29/06.

Looks like I timed this pretty good
Up 19% @ 2.07

Definately one to watch!

Looks like it qualifies for a STEPS entry...comments welcome.

Quote from: stocks2watch2 on December 07, 2006, 01:52:47 PM
Looks like I timed this pretty good
Up 19% @ 2.07

you sure do have a knack for good timing! good job    i bought a few yesterday at 1.70, but funds wont be settled until monday. hope she holds!

Thanks, I'm a little dissapointed in todays trading....Very low volume. I'm holding for now, I still think 1.70 was pretty close to the bottom. Looks like we did ok on HSOA again.

i wanted to sell the rest of hsoa at the open yesterday. i just didnt pull the trigger. i wasnt home to see it drop below 6.35 today. i will wait to see what happens next week before adding more. i missed that cytr run. i was afraid to jump in with unsettled funds! when i can, i owe you a few applauds. thanks!

Healthcare Technologies Ltd. Regains Compliance With Nasdaq Minimum Bid Price Requirement
PR Newswire - December 13, 2006 5:17 AM ET
   

Related Quotes
Symbol   Last Chg
HCTL Trade 2.01 0.00
Real time quote.
 
Healthcare Technologies, Ltd. (NASDAQ: HCTL) announced that on December 12, 2006, it received a notice from the Nasdaq Capital Market indicating that the Company has regained compliance with Nasdaq Marketplace rule 4320(e)(2)(E)(i) (the "Bid Price Rule") because the closing bid price per share for its ordinary shares has been above $1.00 per share for more than 10 consecutive trading days. As a result, the Company has decided not to proceed with the previously announced proposal to effect a reverse stock split of the Company's ordinary shares.

About Healthcare Technologies

Healthcare Technologies through it subsidiaries and affiliate, Gamidor Diagnostics (1984) Ltd., Danyel Biotech Ltd. and Savyon Diagnostics Ltd., specializes in development, manufacturing and marketing of clinical diagnostic test kits and provides services and tools to diagnostic and biotech research professionals in laboratory and point of care sites worldwide.

Quote from: stocks2watch2 on December 13, 2006, 08:38:22 AM
   As a result, the Company has decided not to proceed with the previously announced proposal to effect a reverse stock split of the Company's ordinary shares

that is good news. now we need the volume to pick up!

Ouch!